Detalles de la búsqueda
1.
Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.
J Virol
; 97(7): e0015423, 2023 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37404185
2.
Pleiotropic Effects of Influenza H1, H3, and B Baloxavir-Resistant Substitutions on Replication, Sensitivity to Baloxavir, and Interferon Expression.
Antimicrob Agents Chemother
; 66(4): e0000922, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35262375
3.
Treatment-Emergent Influenza Virus Polymerase Acidic Substitutions Independent of Those at I38 Associated With Reduced Baloxavir Susceptibility and Virus Rebound in Trials of Baloxavir Marboxil.
J Infect Dis
; 222(6): 957-961, 2020 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32253432
4.
Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.
PLoS Pathog
; 14(1): e1006796, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29346435
5.
Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.
PLoS Pathog
; 14(6): e1007141, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29924863
6.
A systematic review of ongoing clinical trials in optic pathway gliomas.
Childs Nerv Syst
; 36(9): 1869-1886, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32556546
7.
Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies.
Virol J
; 16(1): 149, 2019 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31783761
8.
Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility.
Proc Natl Acad Sci U S A
; 111(47): 16854-9, 2014 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-25385602
9.
Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes.
PLoS Pathog
; 10(6): e1004204, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24945804
10.
Reassortment complements spontaneous mutation in influenza A virus NP and M1 genes to accelerate adaptation to a new host.
J Virol
; 87(8): 4330-8, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23365443
11.
Most influenza a virions fail to express at least one essential viral protein.
J Virol
; 87(6): 3155-62, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23283949
12.
Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy.
Proc Natl Acad Sci U S A
; 108(51): E1417-22, 2011 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22106257
13.
Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.
J Virol
; 85(10): 5220-3, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21367910
14.
Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model.
J Virol
; 84(6): 2740-52, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20042504
15.
Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization.
J Virol
; 83(9): 4068-80, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19211740
16.
Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouse.
J Virol
; 83(16): 8254-8, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19494021
17.
Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes.
Nucleic Acids Res
; 36(22): e146, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18948297
18.
The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer.
Oncologist
; 14(1): 22-8, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19144677
19.
Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.
Antiviral Res
; 167: 45-67, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30974127
20.
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.
J Clin Oncol
; 23(25): 5900-9, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16043828